Veritas Pharma Inc. (CSE: VRT, OTCQB: VRTHF, Forum) announced yesterday that it will be sending a research team overseas next week to conduct research on licensed medical cannabis producers and clinical research organizations. The study will be conducted by the Company’s research arm, Cannevert Therapeutics Ltd.
The purpose of the research is to identify potential clinical trial sites as well as sources of cannabis material to be used in such trials. Further information can be found here.
The Company was also in the news yesterday when it announced that it is now tendering bids for the construction of its new cannabis cultivation facility in Sechelt, B.C.
FULL DISCLOSURE: Veritas Pharma Inc. is a paid client of Stockhouse Publishing.